Literature DB >> 16261311

Leptin : adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes : relationship of the index to carotid intima-media thickness.

K Kotani1, N Sakane, K Saiga, Y Kurozawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16261311     DOI: 10.1007/s00125-005-0015-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  12 in total

1.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement.

Authors:  Akira Yamashina; Hirofumi Tomiyama; Kazuhiro Takeda; Hideichi Tsuda; Tomio Arai; Kenichi Hirose; Yutaka Koji; Saburoh Hori; Yoshio Yamamoto
Journal:  Hypertens Res       Date:  2002-05       Impact factor: 3.872

2.  Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients.

Authors:  Noriko Satoh; Mitsuhide Naruse; Takeshi Usui; Tetsuya Tagami; Takayoshi Suganami; Kazunori Yamada; Hideshi Kuzuya; Akira Shimatsu; Yoshihiro Ogawa
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

3.  Sex and topographic differences in associations between large-artery wall thickness and coronary risk profile in a French working cohort: the AXA Study.

Authors:  J Gariepy; J Salomon; N Denarié; F Laskri; J L Mégnien; J Levenson; A Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-04       Impact factor: 8.311

Review 4.  Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence.

Authors:  Michiel L Bots; Joke M Dijk; Anath Oren; Diederick E Grobbee
Journal:  J Hypertens       Date:  2002-12       Impact factor: 4.844

5.  Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.

Authors:  H Taniwaki; T Kawagishi; M Emoto; T Shoji; H Kanda; K Maekawa; Y Nishizawa; H Morii
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

6.  Carotid intima-media thickness in patients with Type 2 diabetes and hypercholesterolemia.

Authors:  F R Montecchi; G Menzinger; A Lala
Journal:  Diabetes Nutr Metab       Date:  2001-02

Review 7.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

Authors:  Joshua A Beckman; Mark A Creager; Peter Libby
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

8.  Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators.

Authors:  G Howard; A R Sharrett; G Heiss; G W Evans; L E Chambless; W A Riley; G L Burke
Journal:  Stroke       Date:  1993-09       Impact factor: 7.914

9.  [Relationship between obesity and atherosclerotic risk in elderly type 2 diabetic patients].

Authors:  Ichiro Wakabayashi; Hiroshi Masuda
Journal:  Nihon Ronen Igakkai Zasshi       Date:  2004-03

10.  Aortic stiffness and carotid intima-media thickness: two independent markers of subclinical vascular damage in young adults?

Authors:  A Oren; L E Vos; C S P M Uiterwaal; D E Grobbee; M L Bots
Journal:  Eur J Clin Invest       Date:  2003-11       Impact factor: 4.686

View more
  26 in total

1.  ApoA1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b.

Authors:  Luca Vanella; Ming Li; DongHyun Kim; Giuseppe Malfa; Lars Bellner; Tomoko Kawakami; Nader G Abraham
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

2.  A prospective evaluation of obesometric parameters associated with renal stone recurrence.

Authors:  Derek Bos; Shawn Dason; Edward Matsumoto; Jehonathan Pinthus; Christopher Allard
Journal:  Can Urol Assoc J       Date:  2016-08       Impact factor: 1.862

3.  Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with Type 2 diabetes.

Authors:  J Zaletel; D Pongrac Barlovic; J Prezelj
Journal:  J Endocrinol Invest       Date:  2010-02-05       Impact factor: 4.256

Review 4.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Dietary exposure to the endocrine disruptor tolylfluanid promotes global metabolic dysfunction in male mice.

Authors:  Shane M Regnier; Andrew G Kirkley; Honggang Ye; Essam El-Hashani; Xiaojie Zhang; Brian A Neel; Wakanene Kamau; Celeste C Thomas; Ayanna K Williams; Emily T Hayes; Nicole L Massad; Daniel N Johnson; Lei Huang; Chunling Zhang; Robert M Sargis
Journal:  Endocrinology       Date:  2014-12-23       Impact factor: 4.736

6.  Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease.

Authors:  Magdalena Mostowik; Grzegorz Gajos; Jaroslaw Zalewski; Jadwiga Nessler; Anetta Undas
Journal:  Cardiovasc Drugs Ther       Date:  2013-08       Impact factor: 3.727

7.  Adiponectin and risk of vascular events in the Northern Manhattan study.

Authors:  Hannah Gardener; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Atherosclerosis       Date:  2012-11-28       Impact factor: 5.162

8.  Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.

Authors:  L J Moran; C Meyer; S K Hutchison; S Zoungas; H J Teede
Journal:  J Endocrinol Invest       Date:  2009-10-15       Impact factor: 4.256

9.  The adiponectin/leptin ratio and metabolic syndrome in healthy korean adult males.

Authors:  Seung-Hyun Ko
Journal:  Korean Diabetes J       Date:  2010-08-31

10.  Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes.

Authors:  A Lasa; J Miranda; M Bulló; R Casas; J Salas-Salvadó; I Larretxi; R Estruch; V Ruiz-Gutiérrez; M P Portillo
Journal:  Eur J Clin Nutr       Date:  2014-02-12       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.